OTC Markets OTCQB - Delayed Quote USD
Telescope Innovations Corp. (TELIF)
0.2100
+0.0100
+(5.00%)
At close: 2:58:02 PM EDT
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Total Revenue
3,906.1200
4,266.2680
2,824.0100
595.3980
--
Cost of Revenue
--
--
3.5000
930.1480
15.6470
Gross Profit
--
--
2,820.5100
-334.7500
-15.6470
Operating Expense
5,486.7570
5,312.6090
3,545.7480
5,422.1500
4,007.9640
Operating Income
-1,580.6370
-1,046.3410
-721.7380
-5,756.9000
-4,023.6110
Net Non Operating Interest Income Expense
-242.7760
-236.5420
--
--
--
Other Income Expense
-58.7750
-40.7700
3.6440
9.8730
-1.7080
Pretax Income
-1,882.1880
-1,323.6530
-718.0940
-5,747.0270
-4,025.3190
Net Income Common Stockholders
-1,882.1900
-1,323.6530
-718.0940
-5,747.0270
-4,025.3190
Diluted NI Available to Com Stockholders
-1,882.1900
-1,323.6530
-718.0940
-5,747.0270
-4,025.3190
Basic EPS
-0.03
-0.02
-0.01
-0.12
-0.08
Diluted EPS
-0.03
-0.02
-0.01
-0.12
-0.08
Basic Average Shares
53,667.0380
53,665.5690
52,716.4060
48,424.4260
47,786.0700
Diluted Average Shares
53,667.0380
53,665.5690
52,716.4060
48,424.4260
47,786.0700
Rent Expense Supplemental
44.7880
29.8030
132.9850
111.5080
4.9000
Total Expenses
5,486.7570
5,312.6090
3,545.7480
6,352.2980
4,023.6110
Net Income from Continuing & Discontinued Operation
-1,882.1900
-1,323.6530
-718.0940
-5,747.0270
-4,025.3190
Normalized Income
-1,823.4150
-1,282.8830
-721.7380
-5,756.9000
-4,023.6110
Interest Expense
242.7760
236.5420
--
--
--
Net Interest Income
-242.7760
-236.5420
--
--
--
EBIT
-1,639.4120
-1,087.1110
-718.0940
-5,756.9000
-4,023.6110
EBITDA
-971.4410
-456.6000
-414.4960
-5,480.5600
-4,023.6110
Reconciled Cost of Revenue
--
--
3.5000
930.1480
15.6470
Reconciled Depreciation
667.9710
630.5110
303.5980
276.3400
--
Net Income from Continuing Operation Net Minority Interest
-1,882.1900
-1,323.6530
-718.0940
-5,747.0270
-4,025.3190
Total Unusual Items Excluding Goodwill
-58.7750
-40.7700
3.6440
9.8730
-1.7080
Total Unusual Items
-58.7750
-40.7700
3.6440
9.8730
-1.7080
Normalized EBITDA
-912.6660
-415.8300
-418.1400
-5,490.4330
-4,021.9030
8/31/2021 - 5/24/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CSBR Champions Oncology, Inc.
7.61
-3.30%
COV.V Covalon Technologies Ltd.
2.2950
+1.10%
GANX Gain Therapeutics, Inc.
1.8800
+1.62%
CGON CG Oncology, Inc.
21.52
+3.81%
COYA Coya Therapeutics, Inc.
6.53
-0.46%
LPTX Leap Therapeutics, Inc.
0.3931
-0.48%
GLPG Galapagos NV
26.49
+3.88%
CLDI Calidi Biotherapeutics, Inc.
0.4973
+3.58%
CRVS Corvus Pharmaceuticals, Inc.
3.6600
+3.98%
RLAY Relay Therapeutics, Inc.
3.1900
+2.57%